Opportunities
Search

Buyer: Gobierno Vasco - Gobernanza, Administración Digital y Autogobierno | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2029-07-01

Buyer: Consejo de Administración-Comité de Inversiones de la Sociedad Estatal Correos y Telégrafos S.A | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-07-01

Buyer: Navarra Impulsa Cultura, Deporte y Ocio, S.L. | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2029-07-03

Buyer: Viešoji įstaiga CPO LT | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-07-03

Buyer: AURAY QUIBERON TERRE ATLANTIQUE | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-07-04

Buyer: Le Mans Métropole Habitat | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2029-07-05

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages grant applications to support research in cancer epidemiology cohort studies that address specific knowledge gaps in cancer etiology and survivorship. Applications should include hypothesis-based research, support for cohort infrastructure and/or maintenance, continued follow-up, and sharing of data and biospecimen resources as appropriate.

This Notice of Funding Opportunity (NOFO) encourages collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate the adoption of promising tools, methods, and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. An application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research and is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical, or translational science. This NOFO will support clinical trials that test functionality or validate performance in the chosen setting. This NOFO is not intended to support conventional clinical trials that lack translation as the primary motivation. Applications that propose phase III clinical trials in any area of research are not sought by and will not be supported through this NOFO. This NOFO does not support commercial production.

This Notice of Funding Opportunity (NOFO) invites applications for innovative research on the factors that cause human behaviors and the oral-systemic health impacts of those behaviors to enhance health, lengthen life, and reduce illness and disability among people with chronic conditions. Causal hypotheses may include biological, biopsychosocial, congenital, environmental, interpersonal, neurological, psychological, and comorbidity factors that individually, sequentially, or in combination trigger human behaviors and oral-systemic health outcomes, with impacts that may be direct or traceably distal. Applications that propose projects to develop or refine causal hypotheses also are encouraged.

This Notice of Funding Opportunity (NOFO) will support, through the cooperative agreement mechanism, investigator-initiated observational studies or biomarker validation studies that require prospective collection of data/biospecimens or continued analysis of data/biospecimens.

This notice of funding opportunity (NOFO) encourages applications for implementation of investigator-initiated, milestone driven clinical trials that need enhanced oversight, and as applicable, include mechanistic studies. Mechanistic work in clinical trials may be of great value because it promotes the understanding of human diseases and the development of future therapeutic modalities. Support is available for clinical trials up to 5 years, as well as for extended clinical trials of 6- or 7-years.Investigators are encouraged to visit this NIH website for additional information about the overall mission and research areas of NIAID.Only one clinical trial may be proposed in each NIAID Clinical Trial Implementation Cooperative Agreement (U01) application. In accordance with NIH standard peer-review processes, the applications will be peer-reviewed, and only meritorious applications will be considered.

Buyer: Valstybės įmonė Ignalinos atominė elektrinė | Notice type: cn-standard | Procedure: restricted | Contract: works | Deadline: 2029-07-07

Buyer: Valstybės įmonė Ignalinos atominė elektrinė | Notice type: cn-standard | Procedure: restricted | Contract: works | Deadline: 2029-07-07

Buyer: VA SYD | Notice type: cn-standard | Procedure: restricted | Contract: works | Deadline: 2029-07-09

Buyer: Viešoji įstaiga CPO LT | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-07-10

The purpose of the Academic Career Excellence (ACE) Award (K32) is to support rigorous, mentored scientific research and career development for up to three years for early-stage postdoctoral scholars. Candidates must submit their application up to one year prior to beginning their postdoctoral position or no more than two years after their postdoctoral training begins (resubmissions included). The ACE K32 will foster early, goal-directed planning and encourage innovative applications with the potential for a significant impact on scientific research and career development. Inclusion of preliminary data are not required as the ACE K32 emphasizes innovative research ideas and thoughtful plans for training and mentorship that will facilitate the development of the postdoctoral scholars who have the potential to become productive, independent investigators in research fields relevant to the missions of the participating NIH Institutes and Centers.

The National Institutes of Health (NIH) will award Institutional Mentored Career Development grants to eligible domestic institutions to support career development programs designed to prepare later stage postdoctoral fellows and junior faculty scholars who have made a commitment to an independent research career for their career advancement and transition to independence. Supported scholars will have "protected time" to engage in intensive, mentored research career development experiences in the fields of biomedical and behavioral research.This Notice of Funding Opportunity (NOFO) does not allow appointed scholars to lead an independent clinical trial but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor. NIH strongly supports training towards a career in clinically relevant research. As such, gaining experience in clinical trials under the guidance of a mentor or co-mentor is encouraged.

Buyer: Consejería Delegada de Actividades de Limpieza y Gestión S.A. | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-07-14

Buyer: Lietuvos oro uostai (PV) | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2029-07-15

Buyer: GYNYBOS RESURSŲ AGENTŪRA PRIE KAM | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-07-16

Buyer: Moravskoslezský kraj | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-07-16

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) announces a program that provides NIAMS-supported K01, K08, K23, and K25 recipients the opportunity to apply for the Small Grant (R03) during the second to fourth year of their K award, as well as to provide support to recipients of significant career development awards from federal or non-federal organizations that are focused on the NIAMS' mission areas. Through this mechanism, which allows up to $50,000 direct costs per year for up to two years, the NIAMS is seeking to enhance the capability of scientists to conduct research as they transition to fully independent investigator. The R03 grant mechanism allows support of different types of projects, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. In addition to the existing career development awards, the R03 is intended to support short term research projects to enable opportunities for a subsequent R01, or equivalent, application. Clinical trials of any phase will not be supported by this NOFO.This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.

Buyer: Giunta Regionale | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-07-18

Buyer: AB „Kelių priežiūra“ | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-07-18

Buyer: AB „Kelių priežiūra“ | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2029-07-18